Situation in 2020 of the requirements for the use of PCSK9 inhibitors in Spain: Results of a national survey Carlos Guijarro; Fernando Civeira; José López-Miranda; Luis Masana; Juan Pedro-Botet; Xavier Pintó; Pedro Valdivielso; José María Mostaza;

Clinical profile of patients treated with evolocumab in lipid/internal medicine units of Spain. Observational study (RETOSS-IMU) Lluís Masana; José López Miranda; Fernando Civeira; Leonardo Reinares; Carlos Guijarro; Núria Plana; Rafael Cuenca; Demetrio Sánchez; José Luis Hernández; Raimundo Andrés; Agustín Blanco; Santiago Villamayor;

SEA 2024 Standards for Global Control of Vascular Risk José María Mostaza; Xavier Pintó; Pedro Armario; Luis Masana; José T. Real; Pedro Valdivielso; Teresa Arrobas-Velilla; Ramón Baeza-Trinidad; Pilar Calmarza; Jesús Cebollada; Miguel Civera-Andrés; José I. Cuende Melero; José L. Díaz-Díaz; Javier Espíldora-Hernández; Jacinto Fernández Pardo; Carlos Guijarro; Carles Jericó; Martín Laclaustra; Carlos Lahoz; José López-Miranda; Sergio Martínez-Hervás; Ovidio Muñiz-Grijalvo; José A. Páramo; Vicente Pascual; Juan Pedro-Botet; Pablo Pérez-Martínez; José Puzo;